Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
07/2003
07/01/2003US6586415 Triazolinethione-phosphoric acid derivatives
07/01/2003US6586357 Stereospecific catalysts; enantioselective reduction; transition metal complexes
07/01/2003US6585780 Phosphinato-substituted propane/butane-polycarboxylic acids useful as crosslinking agents for cellulose materials rendering them wrinkle resistant and/or iron free
06/2003
06/28/2003CA2414265A1 Novel ruthenium complexes and process for preparing alcoholic compounds using these
06/26/2003WO2003051895A1 Processes for preparation of sulphostin and its analogues or intermediates thereof
06/26/2003WO2003051894A1 Preparation of ionic liquids
06/26/2003WO2003051348A2 Composition, synthesis and therapeutic applications of polyamines
06/26/2003US20030120122 Hydrogenation catalysts
06/26/2003US20030120074 Cardioprotective phosphonates and malonates
06/26/2003US20030120071 Chemical compounds
06/26/2003US20030120067 Asymmetric hydrogenation
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119899 Making 3-amido-5-oxy-furan-2-one derivatives by aziding a butenlactone, converting to an amino or an iminophosphorane and coupling with an acid; caspase inhibitors
06/26/2003US20030119868 Gyrase inhibitors and uses thereof
06/26/2003US20030119856 Thiazole compounds useful as inhibitors of protein kinase
06/26/2003US20030119807 Inhibit Procollagen C-proteinase; antiscarring treatment for wounds.
06/26/2003US20030119787 Phosphonic acid derivative having inhibitory activity against carboxypeptidase B
06/26/2003US20030119754 Treating respiratory syncytial virus and human parainfluenza virus infections
06/26/2003US20030119664 Hydrogenation catalyst containing phosphite group
06/26/2003US20030119659 Ligands and asymmetric catalysts made by using the same
06/26/2003US20030119054 Polypeptide immobilization
06/26/2003US20030118999 Complexing with label; immobilization; genetic engineering
06/26/2003US20030118523 Adhesive compositions for hard tissues
06/26/2003CA2510128A1 Composition, synthesis and therapeutic applications of polyamines
06/26/2003CA2469610A1 Method for preparing sulphostin and analogue thereof or preparation intermediate thereof
06/25/2003EP1321470A1 Process for the preparation of alk(en)yl phosphoric acid ester salts
06/25/2003EP1320536A1 $g(a)-SUBSTITUTED $g(b)-AMINOETHYL PHOSPHONATES
06/25/2003EP1320535A1 Method for isolating pharmaceutically exploitable etidronate disodium
06/25/2003EP1320534A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
06/25/2003EP1320518A2 Preparation of enantiomerically-enriched cyclopropylalanine derivatives
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1161436B1 Polyunsaturated fatty acid derivatives and their use in the treatment of cancer
06/25/2003EP1140954B1 Thermosensitive cyclotriphosphazene derivatives and a preparation method thereof
06/25/2003EP1029016A4 Novel chemiluminescent labeling compounds
06/25/2003EP1021388B1 Phosphorylation process and catalyst
06/25/2003EP1000008B1 Novel thyroid receptor ligands and method
06/25/2003CN1426418A Phosphate nucleotide compound'
06/25/2003CN1426417A Phosphorus containing materials, their preparation and use
06/25/2003CN1425673A Adefovir dipivoxil new crystal state, new crystal state composition and its preparing method
06/25/2003CN1112350C Compound phase-transferring quaternary ammonium salt catalyst in beta-hydroxyl structure and its preparation
06/24/2003US6583324 By hydroformylation with rhodium complex catalyst containing an organic phosphite ligand; preventing catalyst poisoning by having the aldehyde remain in the catalyst solution in the separation step
06/24/2003US6583315 Reacting yellow elemental phosphorus with an alkyl halide under alkaline conditions; acidifying, esterifying, isolating and hydrolyzing to obtain purified alkylphosphonous acid; reacting with acetylene
06/24/2003US6583251 Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583177 Leukotriene B4 antagonist compounds and method for treatment
06/24/2003US6583127 Administering phosphatides such as 1-O-octadecyl-2-O-methyl glycero-3-phosphocholine, enantiomers and/or stereisomers as antiinflammatory agents for prophylaxis of inflammatory bowel disease, gastrointestinal or respiratory system disorders
06/24/2003US6583126 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
06/24/2003US6582849 Stable (CF3)2N— salts and process for preparing them
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003050127A1 Preparation method for anhydrous disodium pamidronate
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003008546A3 Biogenic fpa: enzymatic production of formylphosphonic acid by the oxidation of hydroxymethylphosphonic acid
06/19/2003US20030114706 Aminomethylphosphonic acid is contacted with water, an alcohol, a phenol and an oxidizing gas in the presence of a catalyst
06/19/2003US20030114703 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
06/19/2003US20030114695 Gold complexes with 5-phosphino-7-phosphabicyclo(2.2.1) hept-2-ene derivatives; antiproliferative agents
06/19/2003US20030114678 Cardioprotective phosphonates and malonates
06/19/2003US20030114677 Cardioprotective phosphonates and malonates
06/19/2003US20030114675 For ethylene/propylene or ethylene/ alpha-olefin copolymerization and terpolymerization of those monomers with dienes
06/19/2003US20030114666 Antibacterial agents
06/19/2003US20030114661 Disulfone reagents and methods of preparing and using same
06/19/2003US20030114660 Hybrid oligonucleotide
06/19/2003US20030114559 Process for producing a styrenic resin composition
06/19/2003US20030114486 Novel quinolinones and uses thereof
06/19/2003US20030114467 Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof
06/19/2003US20030114422 Thrombosis, brain disorders, cardiovascular disorders, Alzheimer's disease, Huntington diseases
06/19/2003US20030114421 Alpha-substituted beta-aminoethyl phosphonate derivatives
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318868A2 Method for hydroformylation using catalysts of xanthene-bridged ligands
06/18/2003EP1202999B1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs
06/18/2003EP1158995B1 Biologically active compounds of ganoderma pfeifferi dms 13239
06/18/2003EP1021414B1 Frangible compounds for pathogen inactivation
06/18/2003CN1425078A Process for purification of organometallic compounds or heteroato mic organic compounds with a catalyst based on iron and manganese supported on zeolites
06/18/2003CN1425077A Process for purification of organometallic compounds or heteroatomic getter alloys
06/18/2003CN1111538C Tertiary phosphanes containing alkylene clycol groups
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579999 Phosphole and diphosphole ligands for catalysis
06/17/2003US6579997 Metallacrown ether catalysts for hydroformylation
06/17/2003US6579995 Process for phosphorylation and compounds produced by this process
06/17/2003US6579989 Sulphostin analogue and process for producing sulphostin and its analogue
06/17/2003US6579981 Treating herpes virus
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579663 Organometallic monoacylarylphosphines
06/12/2003WO2003048175A1 Ligands for use in catalytic processes
06/12/2003WO2003048174A1 Process for preparation of diphosphine compounds and intermediates for the process
06/12/2003WO2003048173A1 Chiral ligands for asymmetric catalysis
06/12/2003WO2003048172A1 Compounds for determining the activity of phospholipase a¿2?
06/12/2003WO2003047515A2 P2x7 receptor antagonists
06/12/2003WO2002046199A8 Process and ester derivatives useful for preparation of cephalosporins
06/12/2003US20030109754 Preparation of phosphorus-containing compounds useful in the preparation of biphosphine ligands
06/12/2003US20030109737 Reacting phosphoryl chloride with a base; cyclization; forming ifosfamide
06/12/2003US20030109736 Phosphorus compound
06/12/2003US20030109733 From vanadium halide and group 1a organometallic compound
06/12/2003US20030109697 Anticancer agents, infection therapy, autoimmune disease, antiinflammatory agents
06/12/2003US20030109499 Novel compounds and methods for therapy
06/12/2003US20030108944 Combinatorial preparations of phosphorus-containing active compounds and intermediates by solid phase synthesis
06/12/2003US20030108777 Lubricant for magnetic recording medium and use thereof
06/12/2003US20030108486 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
06/11/2003EP1318163A1 New polymer and polymer light-emitting device using the same
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 554